Fall Allergies: The Pharmacist's Role in Allergic Rhinitis Symptom Management and Patient Counseling

Thom Kim Nguyen, PharmD, BCPS, CTTS
Published Online: Monday, August 11, 2014
Supported by educational grants from Meda Pharmaceuticals, Inc, and Merck Sharp & Dohme Corp.

Fall Allergies: The Pharmacist’s Role in Allergic Rhinitis Symptom Management and Patient Counseling

Thom Kim Nguyen, PharmD, BCPS, CTTS
Clinical Assistant Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
Clinical Coordinator, Ambulatory Care
Hunterdon Medical Center
Flemington, New Jersey

Activity Overview
This activity is intended to provide education to community pharmacists on how to identify triggers of allergic rhinitis, as well as manage and counsel patients who suffer from it during the fall.

EDUCATIONAL OBJECTIVES
After participating in this activity, participants should be able to:
  • Identify potential triggers of allergic rhinitis (AR) in the fall
  • Select management strategies for fall AR, including OTC and prescription pharmacotherapy, immunotherapy, allergen avoidance, and alternative medicine
  • Implement effective counseling techniques to assist with optimal symptom management in patients with AR triggered by fall allergens
Target audience: Pharmacists
Type of activity: Knowledge
Release date: August 8, 2014
Expiration date: August 5, 2016
Estimated time to complete activity: 2.0 hours
Fee: Free

Description: Pharmacy Times/Ascend Media Office of Continuing Professional EducationPharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-14-063-H01-P. The activity is available for CE credit through August 5, 2016.


Latest Articles
Pharmacists might be surprised to learn that Pinterest is a hotbed for anti-vaccine sentiment.
The FDA has approved betamethasone dipropionate spray, 0.05%, as a treatment for mild to moderate plaque psoriasis in patients aged 18 years and older.
Medication errors injure thousands of patients annually, and while mistakes occur with all medication classes, those involving antiretroviral therapies are particularly troublesome.
Acute respiratory infections such as the common cold are often accompanied by cough and congestion caused by mucus hypersecretion.
Latest Issues
$auto_registration$